A new study shows that lecanemab, an amyloid-clearing Alzheimer’s therapy, does not improve the brain’s waste-removal network in the short term.

Researchers have used precision-engineered nanoparticles to clear toxic proteins from the brains of mice with ...

Researchers are reporting that an existing drug can roll back key signs of Alzheimer’s disease in mice, restoring memory ...

We have so many things that we can offer early on. It’s heartbreaking when I see patients that are years into these symptoms ...

Scientists have found a potential new treatment target for Alzheimer’s. It comes after a novel technique improved cognitive function in mice with the disease. Alzheimer’s disease is thought to be ...

Semaglutide, the drug behind the blockbuster weight-loss jabs Ozempic and Wegovy, does not slow cognitive decline in people with early-stage Alzheimer's, according to two large new studies.

New FDA validation on organoid studies, first-of-its-kind Tau protein developments, and an advanced AI-designed neutralizing infrastructure have restructured the future of Alzheimer’s research and ...

Advances in the early treatment of Alzheimer's disease can result in extended years of normal living for patients and caregivers alike.